Laboratory Assessment of Covid-19 Immunity in Patients with a Cancer Diagnosis: Alpha to Omicron

Explore a 55-minute keynote presentation on the laboratory assessment of Covid-19 immunity in cancer patients, covering the period from the Alpha to Omicron variants. Delivered by Dr. Balazs Halmos, a distinguished Professor of Oncology and Associate Director of Clinical Research at Albert Einstein College of Medicine/Montefiore Medical Center, this talk delves into the critical intersection of oncology and Covid-19 research. Learn about Dr. Halmos' extensive background in thoracic and head and neck oncology, his focus on translational cancer biology, and his recent work on the impact of Covid-19 on cancer patients. Gain insights into oncogenic alterations, acquired resistance in non-small cell lung cancer, clinical studies in thoracic oncology, and biomarker correlates of novel immunotherapies. Understand the significance of this research, supported by Leukemia Lymphoma Society and NCI awards, in advancing our understanding of Covid-19 immunity in the context of cancer diagnoses.